{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T03:21:54Z","timestamp":1761016914327,"version":"3.44.0"},"reference-count":51,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2012,3,1]],"date-time":"2012-03-01T00:00:00Z","timestamp":1330560000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,3,1]],"date-time":"2012-03-01T00:00:00Z","timestamp":1330560000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","metabolismjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Metabolism"],"published-print":{"date-parts":[[2012,3]]},"DOI":"10.1016\/j.metabol.2011.07.010","type":"journal-article","created":{"date-parts":[[2011,9,23]],"date-time":"2011-09-23T15:14:41Z","timestamp":1316790881000},"page":"349-357","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Prevalence and predictors of abnormal arterial function in statin-treated type 2 diabetes mellitus patients"],"prefix":"10.1016","volume":"61","author":[{"given":"Sandra J.","family":"Hamilton","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gerard T.","family":"Chew","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Timothy M.E.","family":"Davis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gerald F.","family":"Watts","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.metabol.2011.07.010_bb0005","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1056\/NEJM199807233390404","article-title":"Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction","volume":"339","author":"Haffner","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1016\/j.metabol.2011.07.010_bb0010","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/0735-1097(95)00522-6","article-title":"Impaired nitric oxide\u2013mediated vasodilation in patients with non\u2013insulin-dependent diabetes mellitus","volume":"27","author":"Williams","year":"1996","journal-title":"JACC"},{"key":"10.1016\/j.metabol.2011.07.010_bb0015","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/S0735-1097(98)00206-X","article-title":"Smooth muscle dysfunction occurs independently of impaired endothelium-dependent dilation in adults at risk of atherosclerosis","volume":"32","author":"Adams","year":"1998","journal-title":"JACC"},{"key":"10.1016\/j.metabol.2011.07.010_bb0020","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1016\/S0735-1097(03)00994-X","article-title":"The clinical implications of endothelial dysfunction","volume":"42","author":"Widlansky","year":"2003","journal-title":"JACC"},{"key":"10.1016\/j.metabol.2011.07.010_bb0025","doi-asserted-by":"crossref","first-page":"2373","DOI":"10.1161\/CIRCULATIONAHA.107.697045","article-title":"Prognostic significance of brachial flow-mediated vasodilation","volume":"115","author":"Anderson","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.metabol.2011.07.010_bb0030","doi-asserted-by":"crossref","first-page":"2390","DOI":"10.1161\/CIRCULATIONAHA.106.678276","article-title":"Brachial flow-mediated dilation predicts incident cardiovascular events in older adults: the Cardiovascular Health Study","volume":"115","author":"Yeboah","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.metabol.2011.07.010_bb0035","doi-asserted-by":"crossref","first-page":"1899","DOI":"10.1161\/01.CIR.101.16.1899","article-title":"Prognostic impact of coronary vasodilator dysfunction on adverse long-term outcome of coronary heart disease","volume":"101","author":"Schachinger","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/j.metabol.2011.07.010_bb0040","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1042\/CS20060131","article-title":"Brachial artery diameter and vasodilator response to nitroglycerine, but not flow-mediated dilatation, are associated with the presence and quantity of coronary artery calcium in asymptomatic adults","volume":"112","author":"Kullo","year":"2007","journal-title":"Clin Sci"},{"key":"10.1016\/j.metabol.2011.07.010_bb0045","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/j.amjcard.2008.10.008","article-title":"Comparison of effects of rosuvastatin (10 mg) versus atorvastatin (40 mg) on rho kinase activity in Caucasian men with a previous atherosclerotic event","volume":"103","author":"Rawlings","year":"2009","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.metabol.2011.07.010_bb0050","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1210\/jcem.87.2.8249","article-title":"Atorvastatin lowers C-reactive protein and improves endothelium-dependent vasodilation in type 2 diabetes mellitus","volume":"87","author":"Tan","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.metabol.2011.07.010_bb0055","doi-asserted-by":"crossref","first-page":"1K","DOI":"10.1016\/j.amjcard.2008.10.002","article-title":"The Residual Risk Reduction Initiative: a call to action to reduce residual vascular risk in patients with dyslipidemia","volume":"102","author":"Fruchart","year":"2008","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.metabol.2011.07.010_bb0060","doi-asserted-by":"crossref","first-page":"2005","DOI":"10.1016\/S0140-6736(03)13636-7","article-title":"MRC\/BHF Heart Protection Study of cholesterol-lowering with simvastatin in 5963 people with diabetes: a randomised placebo-controlled trial","volume":"361","author":"Collins","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.metabol.2011.07.010_bb0065","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/S0140-6736(04)16895-5","article-title":"Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): multicentre randomised placebo-controlled trial","volume":"364","author":"Colhoun","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.metabol.2011.07.010_bb0070","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.2337\/dc05-2465","article-title":"Effect of lowering LDL cholesterol substantially below currently recommended levels in patients with coronary heart disease and diabetes: the Treating to New Targets (TNT) study","volume":"29","author":"Shepherd","year":"2006","journal-title":"Diabetes Care"},{"issue":"Suppl 1","key":"10.1016\/j.metabol.2011.07.010_bb0075","doi-asserted-by":"crossref","first-page":"S11","DOI":"10.2337\/dc10-S011","article-title":"Standards of medical care in diabetes\u20142010","volume":"33","author":"American Diabetes Association","year":"2010","journal-title":"Diabetes Care"},{"key":"10.1016\/j.metabol.2011.07.010_bb0080","doi-asserted-by":"crossref","first-page":"810","DOI":"10.2337\/dc08-1736","article-title":"Coenzyme Q10 improves endothelial dysfunction in statin-treated type 2 diabetic patients","volume":"32","author":"Hamilton","year":"2009","journal-title":"Diabetes Care"},{"key":"10.1016\/j.metabol.2011.07.010_bb0085","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1042\/CS20090568","article-title":"Fenofibrate improves endothelial function in the brachial artery and forearm resistance arterioles of statin-treated type 2 diabetic patients","volume":"118","author":"Hamilton","year":"2010","journal-title":"Clin.Sci"},{"key":"10.1016\/j.metabol.2011.07.010_bb0090","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1177\/1479164110376206","article-title":"Niacin improves small artery vasodilatory function and compliance in statin-treated type 2 diabetic patients","volume":"7","author":"Hamilton","year":"2010","journal-title":"Diab Vasc Dis Res"},{"key":"10.1016\/j.metabol.2011.07.010_bb0095","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/S0735-1097(01)01746-6","article-title":"Guidelines for the ultrasound assessment of endothelial-dependent flow-mediated vasodilation of the brachial artery: a report of the International Brachial Artery Reactivity Task Force","volume":"39","author":"Corretti","year":"2002","journal-title":"JACC"},{"key":"10.1016\/j.metabol.2011.07.010_bb0100","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1152\/jappl.2001.91.2.929","article-title":"Improved analysis of brachial artery ultrasound using a novel edge-detection software system","volume":"91","author":"Woodman","year":"2001","journal-title":"J Appl Physiol"},{"key":"10.1016\/j.metabol.2011.07.010_bb0105","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1007\/s00125-001-0760-y","article-title":"Coenzyme Q10 improves endothelial dysfunction of the brachial artery in type II diabetes mellitus","volume":"45","author":"Watts","year":"2002","journal-title":"Diabetologia"},{"key":"10.1016\/j.metabol.2011.07.010_bb0110","doi-asserted-by":"crossref","first-page":"604","DOI":"10.7326\/0003-4819-150-9-200905050-00006","article-title":"A new equation to estimate glomerular filtration rate","volume":"150","author":"Levey","year":"2009","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.metabol.2011.07.010_bb0115","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1111\/j.1365-2710.2009.01085.x","article-title":"A systematic review and meta-analysis on the therapeutic equivalence of statins","volume":"35","author":"Weng","year":"2010","journal-title":"J Clin Pharm Ther"},{"key":"10.1016\/j.metabol.2011.07.010_bb0120","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/S0002-9149(03)00530-7","article-title":"Comparison of the efficacy and safety of rosuvastatin versus atorvastatin, simvastatin, and pravastatin across doses (STELLAR Trial)","volume":"92","author":"Jones","year":"2003","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.metabol.2011.07.010_bb0125","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1111\/j.1476-5381.2009.00240.x","article-title":"Endothelium-dependent contractions and endothelial dysfunction in human hypertension","volume":"157","author":"Versari","year":"2009","journal-title":"Brit J Pharmacol"},{"key":"10.1016\/j.metabol.2011.07.010_bb0130","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1177\/000331970005100703","article-title":"Additive effect of coexistent type 2 diabetes and arterial hypertension on endothelial dysfunction in resistance arteries of human forearm vasculature","volume":"51","author":"Preik","year":"2000","journal-title":"Angiology"},{"key":"10.1016\/j.metabol.2011.07.010_bb0135","doi-asserted-by":"crossref","first-page":"2073","DOI":"10.1016\/S0140-6736(10)60674-5","article-title":"Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: a collaborative meta-analysis","volume":"375","author":"Chronic Kidney Disease Prognosis Consortium","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.metabol.2011.07.010_bb0140","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1007\/s00125-010-1854-1","article-title":"Estimated glomerular filtration rate and albuminuria are independent predictors of cardiovascular events and death in type 2 diabetes mellitus: the Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) study","volume":"54","author":"Drury","year":"2011","journal-title":"Diabetologia"},{"key":"10.1016\/j.metabol.2011.07.010_bb0145","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1053\/j.ajkd.2006.08.008","article-title":"Insulin resistance, inflammation, and blood pressure determine vascular dysfunction in CKD","volume":"48","author":"Dogra","year":"2006","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.metabol.2011.07.010_bb0150","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1053\/j.ajkd.2007.03.003","article-title":"A randomized trial of the effect of statin and fibrate therapy on arterial function in CKD","volume":"49","author":"Dogra","year":"2007","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.metabol.2011.07.010_bb0155","doi-asserted-by":"crossref","DOI":"10.1093\/ndt\/gfr049","article-title":"Rosiglitazone does not improve vascular function in subjects with chronic kidney disease","author":"Chan","year":"2011","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.metabol.2011.07.010_bb0160","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1681\/ASN.2005080834","article-title":"Endothelial dysfunction contributes to renal function\u2014associated cardiovascular mortality in a population with mild renal insufficiency: the Hoorn study","volume":"17","author":"Stam","year":"2006","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.metabol.2011.07.010_bb0165","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.molmed.2009.07.001","article-title":"Vascular calcification and bone disease: the calcification paradox","volume":"15","author":"Persy","year":"2009","journal-title":"Trends in Molecular Medicine"},{"key":"10.1016\/j.metabol.2011.07.010_bb0170","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.amjcard.2004.04.022","article-title":"Brachial artery reactivity in asymptomatic patients with type 2 diabetes mellitus and microalbuminuria (from the Detection of Ischemia in Asymptomatic Diabetics-Brachial Artery Reactivity study)","volume":"94","author":"Papaioannou","year":"2004","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.metabol.2011.07.010_bb0175","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.1111\/j.1464-5491.2005.01688.x","article-title":"Urinary albumin levels in the normal range determine arterial wall thickness in adults with type 2 diabetes: a FIELD substudy","volume":"22","author":"Keech","year":"2005","journal-title":"Diabet Med"},{"key":"10.1016\/j.metabol.2011.07.010_bb0180","first-page":"140","article-title":"The burden of chronic kidney disease in Australian patients with type 2 diabetes (the NEFRON study)","volume":"185","author":"Thomas","year":"2006","journal-title":"M JA"},{"key":"10.1016\/j.metabol.2011.07.010_bb0185","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1097\/MAJ.0b013e3181d430ad","article-title":"High prevalence and diversity of kidney dysfunction in patients with type 2 diabetes mellitus and coronary artery disease: the BARI 2D baseline data","volume":"339","author":"Wall","year":"2010","journal-title":"Am J Med Sci"},{"key":"10.1016\/j.metabol.2011.07.010_bb0190","doi-asserted-by":"crossref","first-page":"781","DOI":"10.7326\/0003-4819-154-12-201106210-00005","article-title":"Measuring blood pressure for decision making and quality reporting: where and how many measures?","volume":"154","author":"Powers","year":"2011","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.metabol.2011.07.010_bb0195","doi-asserted-by":"crossref","first-page":"705","DOI":"10.5551\/jat.3848","article-title":"Switching to aggressive statin improves vascular endothelial function in patients with stable coronary artery disease","volume":"17","author":"Hoshiga","year":"2010","journal-title":"J Atheroscler Thromb"},{"key":"10.1016\/j.metabol.2011.07.010_bb0200","doi-asserted-by":"crossref","DOI":"10.1016\/S0140-6736(11)60739-3","article-title":"The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): a randomised placebo-controlled trial","author":"Baigent","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/j.metabol.2011.07.010_bb0205","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1053\/j.ajkd.2009.09.020","article-title":"Effect of lovastatin on primary prevention of cardiovascular events in mild CKD and kidney function loss: a post hoc analysis of the Air Force\/Texas Coronary Atherosclerosis Prevention Study","volume":"55","author":"Kendrick","year":"2010","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.metabol.2011.07.010_bb0210","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1038\/jhh.2010.64","article-title":"How early should blood pressure control be achieved for optimal cardiovascular outcomes?","volume":"25","author":"Weir","year":"2010","journal-title":"J Hum Hypertens"},{"key":"10.1016\/j.metabol.2011.07.010_bb0215","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1016\/S0140-6736(07)61303-8","article-title":"Effects of a fixed combination of perindopril and indapamide on macrovascular and microvascular outcomes in patients with type 2 diabetes mellitus (the ADVANCE trial): a randomised controlled trial","volume":"370","author":"Patel","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.metabol.2011.07.010_bb0220","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1111\/j.1751-7176.2009.00121.x","article-title":"Safety and feasibility of achieving lower systolic blood pressure goals in persons with type 2 diabetes: the SANDS trial","volume":"11","author":"Weir","year":"2009","journal-title":"J Clin Hypertens"},{"key":"10.1016\/j.metabol.2011.07.010_bb0225","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1056\/NEJMoa1001286","article-title":"Effects of intensive blood-pressure control in type 2 diabetes mellitus","volume":"362","author":"Cushman","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/j.metabol.2011.07.010_bb0230","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1001\/jama.2010.884","article-title":"Tight blood pressure control and cardiovascular outcomes among hypertensive patients with diabetes and coronary artery disease","volume":"304","author":"Cooper-DeHoff","year":"2010","journal-title":"JAMA"},{"key":"10.1016\/j.metabol.2011.07.010_bb0235","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1161\/01.HYP.0000166722.91714.ba","article-title":"Vascular and metabolic effects of combined therapy with ramipril and simvastatin in patients with type 2 diabetes","volume":"45","author":"Koh","year":"2005","journal-title":"Hypertension"},{"key":"10.1016\/j.metabol.2011.07.010_bb0240","doi-asserted-by":"crossref","first-page":"2518","DOI":"10.1161\/01.CIR.0000165070.46111.9F","article-title":"Effect of atorvastatin and irbesartan, alone and in combination, on postprandial endothelial dysfunction, oxidative stress, and inflammation in type 2 diabetic patients","volume":"111","author":"Ceriello","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.metabol.2011.07.010_bb0245","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.2337\/dc06-1551","article-title":"Impact of telmisartan versus ramipril on renal endothelial function in patients with hypertension and type 2 diabetes","volume":"30","author":"Schmieder","year":"2007","journal-title":"Diabetes Care"},{"key":"10.1016\/j.metabol.2011.07.010_bb0250","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1053\/j.ajkd.2008.10.041","article-title":"Renal vascular endothelial function in hypertensive patients with type 2 diabetes mellitus","volume":"53","author":"Ritt","year":"2009","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.metabol.2011.07.010_bb0255","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1093\/eurheartj\/ehr017","article-title":"Albuminuria and blood pressure, independent targets for cardioprotective therapy in patients with diabetes and nephropathy: a post hoc analysis of the combined RENAAL and IDNT trials","volume":"32","author":"Holtkamp","year":"2011","journal-title":"Eur Heart J"}],"container-title":["Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002604951100237X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002604951100237X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,21]],"date-time":"2025-09-21T03:55:02Z","timestamp":1758426902000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S002604951100237X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,3]]},"references-count":51,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2012,3]]}},"alternative-id":["S002604951100237X"],"URL":"https:\/\/doi.org\/10.1016\/j.metabol.2011.07.010","relation":{},"ISSN":["0026-0495"],"issn-type":[{"type":"print","value":"0026-0495"}],"subject":[],"published":{"date-parts":[[2012,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prevalence and predictors of abnormal arterial function in statin-treated type 2 diabetes mellitus patients","name":"articletitle","label":"Article Title"},{"value":"Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.metabol.2011.07.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}